Company Snapshot Home > Equity > Corporate Information > Company Snapshot
|
|
| Stock Price Details |
|
Chart |
|
|
Last Price (RS)
|
674.20
|
|
Change (%)
|
14.20 (2.15%)
|
|
Best Buy (RS)
|
673.5(x16)
|
|
Best Sell (RS)
|
674.2(x50)
|
|
Today's Range (RS)
|
665.90
-
686.70
|
|
52-Week Range (RS)
|
579.45
-
873.25
|
|
Beta (1 Year)
|
1.10
|
|
|
|
|
|
| News |
|
Corporate Details |
| Anthem Biosciences allots 1.03 lakh equity shares under ESOP |
| Anthem Biosciences consolidated net profit declines 25.34% in the December 2025 quarter |
| Anthem Biosciences to announce Quarterly Result |
| Anthem Biosciences consolidated net profit rises 7.10% in the September 2025 quarter |
| Anthem Biosciences to announce Quarterly Result |
| Anthem Biosciences Ltd - Anthem Biosciences Limited - Certificate under SEBI (Depositories and Participants) Regulations... |
| Anthem Biosciences Ltd - Anthem Biosciences Limited - Trading Window |
| Anthem Biosciences Ltd - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
| Anthem Biosciences Ltd - Anthem Biosciences Limited - Shareholders meeting |
|
|
|
| Incoporation Year : 2006 |
| Chairman : Ajay Bhardwaj |
| Ownership Group : Indian Private |
| Sector : MAN |
| Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln |
| Registered Office |
Anthem Biosciences Ltd
49 F1 & F2 Canara Bank Road,
Bommasandra Industrial Area,
Bangalore,
Karnataka-560099 |
Phone:+91 080 6672 4000
Fax: |
| E-Mail : investors.abl@anthembio.com |
| URL : http://www.anthembio.com |
|
| Investor Returns |
|
| |
Date |
Price |
Returns (%) |
| 1Week |
02-Mar-2026 |
686.65 |
-3.88 |
| 1Month |
09-Feb-2026 |
673.15 |
-1.95 |
| 3Month |
09-Dec-2025 |
658.35 |
0.25 |
| 6Month |
09-Sep-2025 |
818.90 |
-19.40 |
| 1Year |
21-Jul-2025 |
730.35 |
-9.63 |
|
|
|
|
| Mutual Funds Holding |
|
| Scheme Name |
% Holding |
Market Value (Rs Cr.) |
| Quant Mid Cap Fund |
4.85 |
356.03 |
| Quant Small Cap Fund |
0.93 |
258.27 |
| HSBC Midcap Fund |
1.74 |
216.66 |
| SBI MNC Fund |
2.40 |
140.25 |
| SBI Healthcare Opportunities Fund |
2.68 |
109.38 |
|
|
|
|
| Groups : Pharmaceuticals - Indian - Bulk Drugs & Formln |
|
| Company |
Last Price |
Change (%) |
52Week High |
52Week Low |
Market Cap (Rs Cr.) |
| Sun Pharmaceutical Industries Ltd |
1,806.15 |
-0.08 |
1,850.95 |
1,547.25 |
433,703.79 |
| Dr Reddys Laboratories Ltd |
1,316.05 |
2.30 |
1,377.95 |
1,025.90 |
107,368.48 |
| Cipla Ltd |
1,332.95 |
0.59 |
1,672.20 |
1,283.00 |
107,043.06 |
| Lupin Ltd |
2,335.80 |
1.48 |
2,368.00 |
1,774.00 |
105,197.64 |
| Zydus Lifesciences Ltd |
917.45 |
0.97 |
1,059.00 |
797.05 |
91,431.45 |
|
|
|
|